// App-Quantinova.ai

: Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (FRI).

Researchers

Presenter

  • Omar Usmani

Principal Investigators

  • Wim Vos

  • Benjamin Mignot

  • George Georges

  • Mario Scuri

  • Ilaria Valente

  • Roberta De Maria

  • Nicola Scichilone

Medical Centers

  • Imperial College, London, United Kingdom

  • FLUIDDA NV, Kontich, Belgium,

  • Chiesi Farmaceutici Inc., Cary, United States of America

  • Chiesi Farmaceutici, S.p.A, Parma, Italy,

  • University of Palermo, Palermo, Italy

Locations

  • United Kingdom

  • Belgium

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A